Jane Heffernan

Dr. Jane Heffernan


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SCShannon Collinson
Shannon Collinson
KKKamran Khan
Kamran Khan
JHJane Heffernan
Jane Heffernan
Controlling the spread of influenza to reduce the effects of infection on a population is an important mandate of public health. Mass media reports on an epidemic or pandemic can provide important information to the public, and in turn, can induce positive healthy behaviour practices (i.e., handwashing, social distancing) in the individuals, that will reduce the probability of contracting the disease. Mass media fatigue, however, can dampen these effects. Mathematical models can be used to study the effects of mass media reports on epidemic/pandemic outcomes. In this study we employ a stochastic agent based model to provide a quantification of mass media reports on the variability in important public health measurements. We also include mass media report data compiled by the Global Public Health Intelligence Network, to study the effects of mass media reports in the 2009 H1N1 pandemic. We find that the report rate and the rate at which individuals relax their healthy behaviours (media fatigue) greatly affect the variability in important public health measurements. When the mass media reporting data is included in the model, two peaks of infection result.

4 March 2009 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Closed access
JHJane Heffernan
Jane Heffernan
MKM.J. Keeling
M.J. Keeling
For infectious diseases where immunization can offer lifelong protection, a variety of simple models can be used to explain the utility of vaccination as a control method. However, for many diseases, immunity wanes over time and is subsequently enhanced (boosted) by asymptomatic encounters with the infection. The study of this type of epidemiological process requires a model formulation that can capture both the within-host dynamics of the pathogen and immune system as well as the associated population-level transmission dynamics. Here, we parametrize such a model for measles and show how vaccination can have a range of unexpected consequences as it reduces the natural boosting of immunity as well as reducing the number of naive susceptibles. In particular, we show that moderate waning times (40–80 years) and high levels of vaccination (greater than 70%) can induce large-scale oscillations with substantial numbers of symptomatic cases being generated at the peak. In addition, we predict that, after a long disease-free period, the introduction of infection will lead to far larger epidemics than that predicted by standard models. These results have clear implications for the long-term success of any vaccination campaign and highlight the need for a sound understanding of the immunological mechanisms of immunity and vaccination.

29 August 2012 in Journal of Mathematical Biology
Verified
Journal Article
Closed access
PDF file
YWYan Wang
Yan Wang
YZYicang Zhou
Yicang Zhou
FBFred Brauer
Fred Brauer
JHJane Heffernan
Jane Heffernan

17 April 2014 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SCShannon Collinson
Shannon Collinson
JHJane Heffernan
Jane Heffernan
Mass media is used to inform individuals regarding diseases within a population. The effects of mass media during disease outbreaks have been studied in the mathematical modelling literature, by including ‘media functions’ that affect transmission rates in mathematical epidemiological models. The choice of function to employ, however, varies, and thus, epidemic outcomes that are important to inform public health may be affected.

1 May 2017 in Infectious Disease Modelling
Verified
Journal Article
Open access
SCStanca M. Ciupe
Stanca M. Ciupe
JHJane Heffernan
Jane Heffernan
Understanding the mechanisms governing host-pathogen kinetics is important and can guide human interventions. In-host mathematical models, together with biological data, have been used in this endeavor. In this review, we present basic models used to describe acute and chronic pathogenic infections. We highlight the power of model predictions, the role of drug therapy, and advantage of considering the dynamics of immune responses. We also present the limitations of these models due in part to the trade-off between the complexity of the model and their predictive power, and the challenges a modeler faces in determining the appropriate formulation for a given problem.

1 January 2020 in Vaccine
Verified
Journal Article
Open access
SHStephanie L. Hughes
Stephanie L. Hughes
SBShelly Bolotin
Shelly Bolotin
SKSumaiya Khan
Sumaiya Khan
YLYe Li
Ye Li
CJCaitlin Johnson
Caitlin Johnson
NCNatasha Sarah Crowcroft
Natasha Sarah Crowcroft
In settings where measles has been eliminated, vaccine-derived immunity may in theory wane more rapidly due to a lack of immune boosting by circulating measles virus. We aimed to assess whether measles vaccine effectiveness (VE) waned over time, and if so, whether differentially in measles-eliminated and measles-endemic settings. We performed a systematic literature review of studies that reported VE and time since vaccination with measles-containing vaccine (MCV). We extracted information on case definition (clinical symptoms and/or laboratory diagnosis), method of vaccination status ascertainment (medical record or vaccine registry), as well as any biases which may have arisen from cold chain issues and a lack of an age at first dose of MCV. We then used linear regression to evaluate VE as a function of age at first dose of MCV and time since MCV. After screening 14,782 citations, we identified three full-text articles from measles-eliminated settings and 33 articles from measles-endemic settings. In elimination settings, two-dose VE estimates increased as age at first dose of MCV increased and decreased as time since MCV increased; however, the small number of studies available limited interpretation. In measles-endemic settings, one-dose VE increased by 1.5% (95% CI 0.5, 2.5) for every month increase in age at first dose of MCV. We found no evidence of waning VE in endemic settings. The paucity of data from measles-eliminated settings indicates that additional studies and approaches (such as studies using proxies including laboratory correlates of protection) are needed to answer the question of whether VE in measles-eliminated settings wanes. Age at first dose of MCV was the most important factor in determining VE. More VE studies need to be conducted in elimination settings, and standards should be developed for information collected and reported in such studies.